174 related articles for article (PubMed ID: 23033288)
61. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
[TBL] [Abstract][Full Text] [Related]
62. Immunoglobulin D (IgD) and IgD receptor expression in diffuse large B-cell lymphoma.
Dai X; Wu YJ; Jia XY; Chang Y; Wu HX; Wang C; Wei W
Hematology; 2019 Dec; 24(1):544-551. PubMed ID: 31315540
[No Abstract] [Full Text] [Related]
63. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.
Riihijärvi S; Nurmi H; Holte H; Björkholm M; Fluge O; Pedersen LM; Rydström K; Jerkeman M; Eriksson M; Leppä S
Eur J Haematol; 2012 Nov; 89(5):395-402. PubMed ID: 22882209
[TBL] [Abstract][Full Text] [Related]
64. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
[TBL] [Abstract][Full Text] [Related]
65. Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients.
Azuma M; Shi M; Danenberg KD; Gardner H; Barrett C; Jacques CJ; Sherod A; Iqbal S; El-Khoueiry A; Yang D; Zhang W; Danenberg PV; Lenz HJ
Pharmacogenomics; 2007 Dec; 8(12):1705-13. PubMed ID: 18086000
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of some biochemical markers as prognostic factors in malignant lymphomas.
Salem HA; Eissa LA; Rabbie AM; El-Helw LM; El-Gayar AM
Pak J Pharm Sci; 2006 Jul; 19(3):219-30. PubMed ID: 16935830
[TBL] [Abstract][Full Text] [Related]
67. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma.
Pappa CA; Tsirakis G; Samiotakis P; Tsigaridaki M; Alegakis A; Goulidaki N; Alexandrakis MG
Cancer Invest; 2013 Jul; 31(6):385-9. PubMed ID: 23758184
[TBL] [Abstract][Full Text] [Related]
68. [Expression of the neopterin in serum and urine of the patients with non-Hodgkin's lymphoma].
Cheng XC; Li HC; Zhang R; Tan J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):443-6. PubMed ID: 15972138
[TBL] [Abstract][Full Text] [Related]
69. Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma.
Wu JZ; Tian T; Huang Y; Liang JH; Miao Y; Wang L; Xu J; Qu XY; Fan L; Li JY; Xu W
Cancer Biomark; 2016 Jul; 17(2):205-12. PubMed ID: 27434288
[TBL] [Abstract][Full Text] [Related]
70. Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems.
Lopez-Guillermo A; Montserrat E; Reverter JC; Cervantes F; Escoda L; Tassies D; Blade J; Marin P; Sierra J; Ordi J
Leuk Lymphoma; 1993 May; 10(1-2):101-9. PubMed ID: 8374517
[TBL] [Abstract][Full Text] [Related]
71. CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma.
Hus I; Starosławska E; Bojarska-Junak A; Dobrzyńska-Rutkowska A; Surdacka A; Wdowiak P; Wasiak M; Kusz M; Twardosz A; Dmoszyńska A; Roliński J
Folia Histochem Cytobiol; 2011; 49(1):183-7. PubMed ID: 21526506
[TBL] [Abstract][Full Text] [Related]
72. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
[TBL] [Abstract][Full Text] [Related]
73. [Expressions of VEGF and CXCR4 in diffuse large B cell lymphoma and their clinical significances].
Guo Q; Wang JJ; Li F; Yang HL; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):383-6. PubMed ID: 23628037
[TBL] [Abstract][Full Text] [Related]
74. Concurrent Elevations of VEGF, Osteopontin and MCP-1 Serum Levels Are Independent Predictors of Survival in Patients with Diffuse Large B-Cell Lymphoma.
Duletić-Načinović A; Gačić V; Valković T; Lučin K; Fišić E; Žuvić-Butorac M; Seili-Bekafigo I; Jonjić N
Acta Haematol; 2016; 136(1):52-61. PubMed ID: 27160311
[TBL] [Abstract][Full Text] [Related]
75. An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers.
Gui W; Wang T; Wang J; Wang L; He J; Yang B; Zhao Z; Zhang H; Zhang Q
Int J Biol Markers; 2008; 23(4):207-13. PubMed ID: 19199267
[TBL] [Abstract][Full Text] [Related]
76. Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma.
Wu W; Miao L; Zhao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Wang Y; Jia T
Hematology; 2024 Dec; 29(1):2293514. PubMed ID: 38108323
[TBL] [Abstract][Full Text] [Related]
77. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.
Schneider RJ; Seibert K; Passe S; Little C; Gee T; Lee BJ; Miké V; Young CW
Cancer; 1980 Jul; 46(1):139-43. PubMed ID: 6992974
[TBL] [Abstract][Full Text] [Related]
78. Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphoma.
Endrizzi L; Fiorentino MV; Salvagno L; Segati R; Pappagallo GL; Fosser V
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):945-9. PubMed ID: 6891644
[TBL] [Abstract][Full Text] [Related]
79. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma.
Demir I; Akan OY; Bilgir F; Yilmaz I; Bozkaya G; Bilgir O
Ir J Med Sci; 2024 Jun; 193(3):1201-1207. PubMed ID: 38270775
[TBL] [Abstract][Full Text] [Related]
80. Prognostic impact of β₂-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma.
Yoo C; Yoon DH; Yoon S; Kim S; Huh J; Park CJ; Lee SW; Suh C
Leuk Lymphoma; 2015 Mar; 56(3):688-93. PubMed ID: 24913511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
